Depression: Major Depression & Unipolar Varieties
Resources
Basic Information
Introduction and Types of DepressionRelated Disorders / ConditionsHistorical and Current UnderstandingsBiology, Psychology and SociologyTreatment - Medication and PsychotherapyAlternative Medicine and Self-Help ResourcesSpecial IssuesReferences
More InformationTestsLatest News
Spouse's Deployment Status Tied to Depression RiskMany With Depression Have Periods of HypomaniaBrain Research May Help Predict Anxiety, Depression in YoungAddictive Internet Use Tied to Depression in TeensMood Disorders Going Undetected in U.S. ChildrenDepression Linked to Higher Risk of Alzheimer's, DementiaDepression Can Make Pain WorseHealth Tip: Don't Suddenly Stop AntidepressantsPost-Combat Stress Disrupting Daily Lives of Returning VetsBrain Injury Patients Plagued by Poor Sleep, DepressionFor Depression, Phone Therapy May Be an AnswerMajor Depression Often Follows Brain InjuryOlder Adults Have Lower Rates of Mood, Anxiety DisordersNo One Antidepressant Raises Suicide Risk More Than OthersMedian Duration of Bipolar I Mood Episodes Is 13 WeeksHelp for Depressed Latinos Often Hampered by StigmaCombination Treatment May Help Depressed AlcoholicsPassive Response to Social Stress Linked to DepressionSurvey May Help Docs Diagnose Mood DisordersPeople With Asthma More Likely to Be DepressedInternet Addicts More Prone to DepressionGenetic Variants in Depressed People Raise Suicide RiskClinical Trials Update: Feb. 1, 2010Clinical Trials Update: Jan. 25, 2010Stress, Anxiety Can Up Risk of Depression in PregnancyClinical Trials Update: Jan. 12, 2010Most Depressed Adults Going Without TreatmentAntidepressants Reduce Odds of Suicidal Teens' ReadmissionClinical Trials Update: Dec. 7, 2009Fear of Anxiety May Lead to DepressionDepressed Nonresident Fathers Less Close to SonsClinical Trials Update: Nov. 9, 2009Adjunctive Psychotherapy for Depression StudiedCognitive Behavioral Therapy Helps Overcome Winter BluesPsychotherapy Beats Light Treatment for SADPhone Counseling for Depression Rings With PromiseImpact of Maternal Depression and Abuse on Children StudiedDepression, Anxiety May Raise Odds of ObesityTelephone Care and Therapy Help to Treat DepressionMother's Use of Antidepressant May Carry Risks for NewbornTroubled Minds Can Mean Wider WaistlinesTeens With ADHD, Depression Risk Internet AddictionDrinking, Weight, Depression Linked in Young Women: Study
LinksSelf-Help Groups
Related Topics

Anxiety Disorders
Bipolar Disorder
Suicide
Addictions: Alcohol and Substance Abuse
Pain Management

SSRIs Linked to Upper Gastrointestinal Bleeding

HealthDay News
by -- Eric Metcalf
Updated: Dec 14th 2009

new article illustration

MONDAY, Dec. 14 (HealthDay News) -- Selective serotonin reuptake inhibitors (SSRIs) are associated with an increased risk of upper gastrointestinal bleeding, which warrants caution when prescribing these drugs in patients at elevated risk for this type of bleeding, according to research published in the December issue of Clinical Gastroenterology and Hepatology.

Michael Dall, M.D., of the University of Southern Denmark in Odense, and colleagues analyzed data from 3,652 patients admitted to the hospital with peptic ulcer or gastritis with significant bleeding, as well as more than 36,000 matched controls.

The researchers found that current, recent, and past users of SSRIs had higher risk of upper gastrointestinal bleeding (odds ratios, 1.67, 1.88, and 1.22, respectively). Taking an SSRI and non-steroidal anti-inflammatory drug concurrently was associated with an even higher risk (odds ratio, 8.0), as was concurrently taking an SSRI, NSAID and aspirin (odds ratio, 28).

"Several case reports have suggested that SSRIs may induce bleeding. The pharmacological mechanism underlying this potential adverse effect is well described. The release of serotonin (5-HT) in platelets is important for their aggregation. Platelets are unable to synthesize serotonin, which is taken up from the circulation by serotonin transporters. SSRIs inhibit these transporters and will lower the level of serotonin inside the platelets after several weeks of treatment," the authors write. "In conclusion, the decision to treat a patient with SSRIs should be very carefully considered in patients at high risk of upper gastrointestinal bleeding and in users of ulcerogenic drugs."

Two co-authors reported financial relationships with AstraZeneca, as well as other pharmaceutical companies and entities.

Abstract
Full Text (subscription or payment may be required)



Administration
650 Green Street
P.O. Box 973
Stephenville,TX. 76401
(254)965-7806
(254)965-7808

Crisis Hotline
(800) 772-5987


powered by centersite dot net